🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Akero Therapeutics, Inc.

Akero Therapeutics, Inc. logo
Market Cap: High
Employees: Lowest

efruxifermin (EFX)

Akero Therapeutics, Inc., a cardio-metabolic NASH company, develops medicines for restoring metabolic balance and improving health. Efruxifermin (EFX) is its lead product, undergoing a Phase 2a clinical trial to treat NASH.

Tags: Biotechnology, Clinical Trials, Metabolic Health, NASH, Pharmaceuticals

Website

About | About | About | Contact | Contact | Contact | Careers | About | About | About

Symbol: AKRO

Recent Price: $27.96

Industry: Biotechnology

CEO: Dr. Andrew Cheng M.D., Ph.D.

Sector: Healthcare

Employees: 61

Address: 601 Gateway Boulevard, South San Francisco, CA 94080

Phone: 650 487 6488

Last updated: 2024-12-31